Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Fair

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
The Journal of Urology|October 1, 1982
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective studyW R Fair, W D Heston, D Kadmon, et al.
Annals of Internal Medicine|April 1, 1988
Advanced seminoma: the role of chemotherapy and adjunctive surgeryR J Motzer, G J Bosl, N L Geller, et al.
Molecular Urology|November 4, 2000
Three-dimensional ultrasound analyses of the prostateE J Feleppa, W R Fair, T Liu, et al.
The Journal of Urology|April 1, 1989
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethraP R Bretton, H W Herr, W F Whitmore, et al.
The Journal of Urology|July 1, 1987
Fertility status of patients with clinical stage I testis tumors on a surveillance protocolP R Carroll, M J Morse, W F Whitmore, et al.
The Journal of Urology|February 1, 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformationJ Sheinfeld, V E Reuter, M R Melamed, et al.
Histology and Histopathology|May 16, 2000
Expression of c-kit and kit-ligand in benign and malignant prostatic tissuesR Simak, P Capodieci, D W Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
The Journal of Urology|October 1, 1982
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective studyW R Fair, W D Heston, D Kadmon, et al.
Annals of Internal Medicine|April 1, 1988
Advanced seminoma: the role of chemotherapy and adjunctive surgeryR J Motzer, G J Bosl, N L Geller, et al.
Molecular Urology|November 4, 2000
Three-dimensional ultrasound analyses of the prostateE J Feleppa, W R Fair, T Liu, et al.
The Journal of Urology|April 1, 1989
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethraP R Bretton, H W Herr, W F Whitmore, et al.
The Journal of Urology|July 1, 1987
Fertility status of patients with clinical stage I testis tumors on a surveillance protocolP R Carroll, M J Morse, W F Whitmore, et al.
The Journal of Urology|February 1, 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformationJ Sheinfeld, V E Reuter, M R Melamed, et al.
Histology and Histopathology|May 16, 2000
Expression of c-kit and kit-ligand in benign and malignant prostatic tissuesR Simak, P Capodieci, D W Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
Pageof 29